NL1008716C2 - Farmaceutisch preparaat. - Google Patents

Farmaceutisch preparaat. Download PDF

Info

Publication number
NL1008716C2
NL1008716C2 NL1008716A NL1008716A NL1008716C2 NL 1008716 C2 NL1008716 C2 NL 1008716C2 NL 1008716 A NL1008716 A NL 1008716A NL 1008716 A NL1008716 A NL 1008716A NL 1008716 C2 NL1008716 C2 NL 1008716C2
Authority
NL
Netherlands
Prior art keywords
tablets
acid
folic acid
acetylsalicylic acid
mixture
Prior art date
Application number
NL1008716A
Other languages
English (en)
Dutch (nl)
Inventor
Johanna Maria Pieterne Vermeer
Hendrik Visscher
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Priority to NL1008716A priority Critical patent/NL1008716C2/nl
Priority to EP99200915A priority patent/EP0947198A1/fr
Application granted granted Critical
Publication of NL1008716C2 publication Critical patent/NL1008716C2/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL1008716A 1998-03-26 1998-03-26 Farmaceutisch preparaat. NL1008716C2 (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL1008716A NL1008716C2 (nl) 1998-03-26 1998-03-26 Farmaceutisch preparaat.
EP99200915A EP0947198A1 (fr) 1998-03-26 1999-03-24 Compositions pharmaceutiques contenant de l'acide folique et de l'acide acétylsalicylique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1008716A NL1008716C2 (nl) 1998-03-26 1998-03-26 Farmaceutisch preparaat.
NL1008716 1998-03-26

Publications (1)

Publication Number Publication Date
NL1008716C2 true NL1008716C2 (nl) 1999-09-28

Family

ID=19766827

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1008716A NL1008716C2 (nl) 1998-03-26 1998-03-26 Farmaceutisch preparaat.

Country Status (2)

Country Link
EP (1) EP0947198A1 (fr)
NL (1) NL1008716C2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US11166966B2 (en) * 2017-11-03 2021-11-09 Roxane Handal-Orefice Compounds for prenatal treatment comprising a natal vitamin and aspirin and methods for making and using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CIESIELSKI-CARLUCCI, C._LEE, B. K._BOXER, L. M._LEUNG, L. L.: "WOMAN WHO HAD A STROKE, THEN A MYOCARDIAL INFARCTION", LANCET, 26 April 1997 (1997-04-26), XP002086039 *
GENSINI G F_(A): "Classical risk factors and emerging elements in the risk profile for coronary artery disease.", EUROPEAN HEART JOURNAL, February 1998 (1998-02-01), XP002086038 *

Also Published As

Publication number Publication date
EP0947198A1 (fr) 1999-10-06

Similar Documents

Publication Publication Date Title
EP2755648B1 (fr) Formulations d'un inhibiteur d'histone désacétylase en combinaison avec la bendamustine et leurs utilisations
US7947681B2 (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
CN100448439C (zh) 用于头痛、偏头痛、恶心和呕吐的药物组合物
ES2569553T3 (es) Cápsula para la prevención de enfermedades cardiovasculares
US20120258172A1 (en) Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
Coolen et al. Oral bioavailability of ATP after prolonged administration
KR20090017423A (ko) HMG­CoA 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법
Herrero-Beaumont et al. Use of crystalline glucosamine sulfate in osteoarthritis
CA2835272A1 (fr) Composition pharmaceutique antiretrovirale
CN109414423A (zh) 包含丙戊酸的延迟释放药物制剂和其用途
NL1008716C2 (nl) Farmaceutisch preparaat.
ES2342885T3 (es) Composiciones farmaceuticas de liberacion controlada estables que contienen fenofibrato y pravastatina.
Aman et al. Studies of food drug interactions.
RU2651460C2 (ru) Комбинированная композиция, содержащая метформин замедленного высвобождения и ингибитор HMG-CoA-редуктазы немедленного высвобождения
CN101352425A (zh) 一种复方渗透泵控释制剂及其制备方法
US20190111064A1 (en) Statin + vitamin d combination drug and method of use
CN101385729A (zh) 一种治疗高脂血症的渗透泵控释制剂组合物及其制备方法
CN101385731A (zh) 治疗高脂血症的渗透泵控释制剂组合物及其制备方法
JP2011068647A (ja) アスパラギン酸又はその塩含有固形製剤
CN101385719B (zh) 一种治疗高血脂症的渗透泵制剂组合物
CN101897711B (zh) 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途
US20230181475A1 (en) Composition comprising methylfolate
US20230088240A1 (en) Accelerating the drying rate of softgel capsules
Lombardi et al. Nutrition in the age of polypharmacy
CN101897710A (zh) 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸的药物组合物及其用途

Legal Events

Date Code Title Description
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20021001